What human evidence supports nutrition during GLP-1-based treatment, and which conclusions still need dedicated studies?
The intended reader works in R&D or scientific marketing. The aim is to navigate clinical findings, nutritional priorities and studies still to be completed.
PDF / 8 PAGES
Inside the document.
Three pages from the actual PDF: synthesis, data and method. Open a preview to read it at full size.
The sources answer different questions. The dossier preserves that distinction through to its conclusion.
01
Lean mass needs a precise reading.
Weight, fat mass and lean mass all fell in the SURMOUNT-1 DXA substudy. They are different measures, each relative to its own baseline. DXA does not measure muscle alone, and the trial does not test a protein supplement. [S01]
02
The intervention context matters.
A trial combining exercise and liraglutide supports studying combined programmes. Its findings belong to that medicine, training programme and population; they do not establish the effect of a nutraceutical formulation. [S02]
03
New questions have dedicated studies.
LEAN-PREP plans to study protein and exercise; VITAGLP a multivitamin. In the documents consulted, the former is a protocol and the latter a registration with no posted results. Design, planned enrolment and observed outcomes must remain distinct. [S04, S05]
HOW IT WAS MADE
From research to checking.
AI assisted research across sources, evidence organisation and drafting. Editorial checks traced numbers, samples, comparators and study status back to the original documents.
01Define the question
02Search and connect
03Check the sources
04Deliver the dossier
Research conducted in Codex on 24 October 2026, with web consultation and original-source checks. A targeted synthesis, not a systematic review or independent clinical validation.
A prompt for repeating the approach
A reusable template drawn from this case’s brief and checks. Adapt the question, audience and date; always check the output against the sources.
REUSABLE BRIEF / GMA AI LAB
Question: What human evidence supports nutrition during GLP-1-based treatment, and which conclusions still need dedicated studies?
Readers: R&D and scientific marketing. Search cut-off: 24 October 2026 (update it when repeating the work).
Find original human studies, relevant consensus documents and registrations. Retain author, title, date, DOI or identifier and link. State whether you read the abstract or full text.
For each study extract population, planned and analysed sample, intervention, comparator, duration, measure and outcome. Distinguish lean mass, muscle and function; retain uncertainty, negative findings, funding and limitations. Check corrections. Do not treat protocols or registrations as findings, or add samples from related studies.
Prepare a readable synthesis with an evidence matrix, open questions and bibliography. Separate source conclusions from proposed research. Check references, numbers and wording before using the document.
This is a reusable template, not a conversation log or a guarantee of identical output.